Evidence map›Paper›PMID 19376871›Full record

ArticleJournal of bacteriology2009

Comparative genome-scale metabolic reconstruction and flux balance analysis of multiple Staphylococcus aureus genomes identify novel antimicrobial drug targets.

Deok-Sun Lee, Henry Burd, Jiangxia Liu, Eivind Almaas, Olaf Wiest, Albert-László Barabási, Zoltán N Oltvai, Vinayak Kapatral

Open access · greenAbstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of bacteriology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 156 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Deok-Sun LeeCenter for Complex Network Research, Northeastern University, Boston, Massachusetts 022151, USA.
Henry Burd
Jiangxia Liu
Eivind Almaas
Olaf Wiest
Albert-László Barabási
Zoltán N Oltvai
Vinayak Kapatral
Dana-Farber Cancer Institute · USIgenbio (United States) · USUniversity of Pittsburgh · USLawrence Livermore National Laboratory · USUniversity of Notre Dame · US

Funding

Genomic Analysis of Network Perturbations in Human DiseaseP50HG004233 · NHGRI · DANA-FARBER CANCER INST · PI VIDAL, MARC · 2007 to 2017
$31.6M
Integrated Antimicrobial Drug Discovery Scheme for Multidrug Resistant BacteriaU01AI070499 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI OLTVAI, ZOLTAN N. · 2006 to 2010
$3.0M
NHGRI NIH HHS P50 HG004233NIAID NIH HHS 5U01AI070499-02NIAID NIH HHS U01 AI070499
6 · The paper itself

Abstract

Mortality due to multidrug-resistant Staphylococcus aureus infection is predicted to surpass that of human immunodeficiency virus/AIDS in the United States. Despite the various treatment options for S. aureus infections, it remains a major hospital- and community-acquired opportunistic pathogen. With the emergence of multidrug-resistant S. aureus strains, there is an urgent need for the discovery of new antimicrobial drug targets in the organism. To this end, we reconstructed the metabolic networks of multidrug-resistant S. aureus strains using genome annotation, functional-pathway analysis, and comparative genomic approaches, followed by flux balance analysis-based in silico single and double gene deletion experiments. We identified 70 single enzymes and 54 pairs of enzymes whose corresponding metabolic reactions are predicted to be unconditionally essential for growth. Of these, 44 single enzymes and 10 enzyme pairs proved to be common to all 13 S. aureus strains, including many that had not been previously identified as being essential for growth by gene deletion experiments in S. aureus. We thus conclude that metabolic reconstruction and in silico analyses of multiple strains of the same bacterial species provide a novel approach for potential antibiotic target identification.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsDrug DiscoveryGenome, BacterialGenomicsMetabolic Networks and PathwaysMetabolomicsStaphylococcus aureusAnti-Bacterial AgentsBacterial Proteins

Identifiers

PMID19376871
PMCPMC2698402
OpenAlexW2127872845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.